TRENDING :  Market Movers  |  Top 50   AAPL (-0.23%)    FB (-0.89%)    KO (-0.77%)    AMZN (-0.91%)    UGAZ (4.96%)    VXXB (-3.5%)    MGM (3.07%)    MDB (1.02%)    KRE (2.17%)    AMD (2.38%)    ABMD (1.19%)    AA (0.25%)    IVC (12.08%)    HTGM (2.18%)    GOOS (-2.76%)    GH (4.51%)    GEVO (1.66%)    FUV (-31.27%)    FCEL (12.84%)    DIS (1.75%)    DGAZ (-4.98%)    CRON (2.26%)    CRM (-0.27%)    CGC (3.13%)    CAT (2.7%)

 ISR - IsoRay

$0.39 [-0.01][-0.52%]

Next Earnings

5/2/2019

AMC

Recommend
Trade Idea »



ANALYST RATINGS

Quarterly Rating Chart
Rating

2


1=Strong Buy, 2=Buy, 3=Hold, 4=Underperform, 5=Sell
Price Targets
High $0.70
Low $0.70
Average $0.70
Current $0.39

CompanyAnalyst NamePT ActionActionRatingTargetDate
H.C. WainwrightAnnouncesAssumesBuy$0.7001/28/19
*Last 90 days

OPEN RECOMMENDATIONS

No recommendations found.


This list is limited to recommendations made in last 7 days only. Subscribe to a service to see all their recommendations.

TRADERS TRACKING $ISR

No traders tracking are currently recommending this stock

TRENDING ARTICLES



IsoRay (ISR) Reports Q2 Loss, Tops Revenue Estimates

02/13/19
IsoRay ISR came out with a quarterly loss of 0 02 per share in line with the Zacks Consensus Estimate This compares to loss of 0 03 per share a year ago These figures are adjusted for non recurring items A quarter ago it was expected that this isotope based medical products maker

IsoRay (ISR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

02/05/19
IsoRay ISR is expected to deliver a year over year increase in earnings on higher revenues when i t report s results for the quarter ended December 2018 This widely known consensus outlook gives a good sense of the company s earnings picture but how the actual results compare to